Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.9915
0.00 (0.00%)
Jul 2, 2026, 4:00 PM EDT - Market closed
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $92.25 million as of July 6, 2026. Its market cap has increased by 131.33% in one year.
Market Cap
92.25M
Enterprise Value
92.73M
1-Year Change
131.33%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.87M to $92.25M, a decrease of -41.93%. That is a compound annual growth rate of -5.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 92.25M | 202.53% |
| Dec 31, 2025 | 30.49M | -38.81% |
| Dec 31, 2024 | 49.83M | 234.56% |
| Dec 29, 2023 | 14.89M | 38.39% |
| Dec 30, 2022 | 10.76M | -78.89% |
| Dec 31, 2021 | 50.98M | 20.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alps Group | 98.01M |
| PolyPid | 96.25M |
| Rani Therapeutics Holdings | 95.55M |
| Adicet Bio | 94.51M |
| ImmuCell | 93.09M |
| Pelthos Therapeutics | 89.57M |
| Seer, Inc. | 89.07M |
| MAIA Biotechnology | 88.16M |